SCHEMBL30973333

SCHEMBL30973333

Cc1cc(C(F)(F)F)cc(O)c1-c1cc2occ(C3=CCCN(C)C3)c2nn1

nearest known ligand 0.43

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
IL1B P01584 20/20 0.43
NLRP3 Q96P20 4/20 0.42
TNF P01375 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30973461 0.74 IL1B (0.57) IL1BNLRP3TNF
SCHEMBL30973284 0.70 IL1B (0.37) IL1BNLRP3
SCHEMBL30973542 0.67 IL1B (0.56) IL1BNLRP3TNF
SCHEMBL22695045 0.65 IL1B (0.61) IL1BNLRP3TNF
SCHEMBL31199651 0.64 IL1B (0.57) IL1BNLRP3TNF
SCHEMBL22695042 0.62 IL1B (0.57) IL1BNLRP3TNF
SCHEMBL22655138 0.62 IL1B (0.57) IL1BNLRP3TNF
SCHEMBL31637350 0.61 IL1B (0.47) IL1BNLRP3TNF
SCHEMBL22654806 0.60 IL1B (1.00) IL1BNLRP3TNF
SCHEMBL22654980 0.60 IL1B (1.00) IL1BNLRP3TNF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4642784-A1 HETEROCYCLIC AND HETEROARYL COMPOUNDS AS INHIBITORS OF NLRP3 PTC Therapeutics, Inc. (US) 2025-11-05 EP claimed
WO-2024145623-A1 HETEROCYCLIC AND HETEROARYL COMPOUNDS AS INHIBITORS OF NLRP3 PTC THERAPEUTICS, INC. (US) 2024-07-04 WO claimed